Fighting COVID-19 With... Llamas?!

TL;DR

Scientists have found that antibodies from llamas, especially those from a llama named Winter, could potentially be more effective in fighting COVID-19 compared to human antibodies.

Transcript

this episode was filmed on May 19 2020 if we have more recent videos about the pandemic you can find them in our kovat 19 playlist which we will link in the description in our last episode of scishow News we talked about how scientists are looking into whether the serum pulled from the blood of people who've recovered from kovat 19 can be used to h... Read More

Key Insights

• 🛩️ Llama antibodies, specifically single domain antibodies, are smaller, more stable, and potentially more effective in targeting the COVID-19 virus.
• 🧑‍🌾 Winter, a llama previously immunized with spike proteins, produced antibodies that can neutralize both SARS and MERS viruses, as well as COVID-19.
• 🦙 Large-scale production of llama antibodies is possible through genetic modification and manufacturing by bacteria or yeast.
• ✋ Llama antibodies could serve as a preventative treatment or a shield for healthcare workers and individuals at high risk of exposure.

Questions & Answers

Q: What makes llama antibodies potentially more effective in fighting COVID-19?

Llama antibodies, known as single domain antibodies, are more stable and smaller in size compared to human antibodies, allowing them to reach and bind to the virus more effectively.

Q: How were llama antibodies tested against COVID-19?

Llamas were immunized with spike proteins from the SARS and MERS viruses. The antibodies produced by Winter, one of the llamas, were found to be effective in neutralizing both viruses and also show promise in combating COVID-19.

Q: Can llama antibodies be produced on a large scale?

Yes, llama antibodies can be genetically modified and manufactured by bacteria or yeast, making large-scale production feasible.

Q: Besides therapeutics, how else can llama antibodies benefit in the fight against COVID-19?

Llama antibodies could be used as a preventative treatment for healthcare workers or individuals likely to be exposed to the virus. They could also improve the accuracy and affordability of diagnostic tests.

Summary & Key Takeaways

• Scientists are investigating the use of llama antibodies, specifically single domain antibodies, as a potential treatment for COVID-19.

• Llamas naturally produce miniature antibodies that are more stable and smaller in size, making them potentially more effective in targeting the virus.

• Winter, a llama previously immunized with spike proteins from SARS and MERS viruses, produced antibodies that can neutralize both viruses and shows promise in fighting COVID-19.